High Throughput Genomics has appointed John Wineman to be vice president of new business development for the company's western region, and has hired Thomas Vasicek as vice president of clinical programs and product innovation, the Tucson, Ariz.-based firm said this week.
Prior to joining HTG, Wineman served as director of business development for FEI's life science market division. Before that, he served as director of strategic marketing and director of corporate development for Ventana Medical Systems, now part of Roche. Wineman holds an MBA from San Diego State University and a BS in biology from Oregon State University.
Before joining HTG, Vasicek was senior director of medical innovation for Ventana Medical Systems. He previously served as senior director of bioscience technology development at Medtronic. Vasicek holds a PhD in genetics from Harvard University.
Linda Rubinstein has been named a partner at FLG Partners, a consulting and services firm.
Rubinstein previously was chief financial officer of Solexa. She also served as vice president of finance of ChemoCentryx and senior vice president of Lehman Brothers' Global Healthcare Group. Rubinstein currently sits on the board of directors of Sensorin. She holds a BA and an MA in economics from the University of California, Los Angeles.
WaferGen Biosystems this week appointed Donald Huffman as its new chief financial officer. Huffman recently was CFO at Asante Solutions. Before that, he was CFO at Guava Technologies, now Millipore; EndoSonics, now Volcano; Microcide Pharmaceuticals; Celtrix Pharmaceuticals; and Sanderling Ventures.